190 related articles for article (PubMed ID: 28645646)
1. Association of bullous pemphigoid with malignancy: A systematic review and meta-analysis.
Atzmony L; Mimouni I; Reiter O; Leshem YA; Taha O; Gdalevich M; Hodak E; Mimouni D
J Am Acad Dermatol; 2017 Oct; 77(4):691-699. PubMed ID: 28645646
[TBL] [Abstract][Full Text] [Related]
2. Association Between Medication Use and Bullous Pemphigoid: A Systematic Review and Meta-analysis.
Liu SD; Chen WT; Chi CC
JAMA Dermatol; 2020 Aug; 156(8):891-900. PubMed ID: 32584924
[TBL] [Abstract][Full Text] [Related]
3. Prevalence of diabetes mellitus in bullous pemphigoid patients in the absence of dipeptidyl peptidase-4 inhibitors: a systematic review and meta-analysis.
Guo W; Rathi S; Marquez J; Smith H; Kuruvilla A; Tonnesen MG; Salvemini JN
Arch Dermatol Res; 2023 Oct; 315(8):2207-2213. PubMed ID: 36867222
[TBL] [Abstract][Full Text] [Related]
4. Bullous Pemphigoid and Malignancy in Two Different Hospital Populations: A Retrospective Cohort Review.
Wright B; Halper K; Worswick S
Oncology; 2020; 98(5):318-320. PubMed ID: 32182611
[TBL] [Abstract][Full Text] [Related]
5. Association between bullous pemphigoid and malignancy: A meta-analysis.
Lucariello RJ; Villablanca SE; Mascaró JM; Reichel M
Australas J Dermatol; 2018 Nov; 59(4):253-260. PubMed ID: 29313891
[TBL] [Abstract][Full Text] [Related]
6. Risk of venous thromboembolism in patients with bullous pemphigoid: A systematic review and meta-analysis.
Ungprasert P; Wijarnpreecha K; Thongprayoon C
Indian J Dermatol Venereol Leprol; 2018; 84(1):22-26. PubMed ID: 29185440
[TBL] [Abstract][Full Text] [Related]
7. Association between bullous pemphigoid and psoriasis: Systematic review and meta-analysis of case-control studies.
Phan K; Goyal S; Murrell DF
Australas J Dermatol; 2019 Feb; 60(1):23-28. PubMed ID: 30141189
[TBL] [Abstract][Full Text] [Related]
8. Association between bullous pemphigoid and psychiatric disorders: A systematic review and meta-analysis.
Huang IH; Wu PC; Liu CW; Huang YC
J Dtsch Dermatol Ges; 2022 Oct; 20(10):1305-1312. PubMed ID: 36108333
[TBL] [Abstract][Full Text] [Related]
9. The association between neurological diseases, malignancies and cardiovascular comorbidities among patients with bullous pemphigoid: Case-control study in a specialized Polish center.
Kalińska-Bienias A; Kowalczyk E; Jagielski P; Bienias P; Kowalewski C; Woźniak K
Adv Clin Exp Med; 2019 May; 28(5):637-642. PubMed ID: 30784240
[TBL] [Abstract][Full Text] [Related]
10. Prevalence, Spectrum and Clinical Implications of Malignancies in Patients with Bullous Pemphigoid.
Baum S; Steinberg S; Tzanani I; Barzilai A; Lyakhovitsky A
Acta Derm Venereol; 2023 Mar; 103():adv00888. PubMed ID: 36916952
[TBL] [Abstract][Full Text] [Related]
11. The association between bullous pemphigoid and cognitive outcomes in middle-aged and older adults: A systematic review and meta-analysis.
Zhou Q; Xiong Z; Yang D; Xiong C; Li X
PLoS One; 2023; 18(11):e0295135. PubMed ID: 38033098
[TBL] [Abstract][Full Text] [Related]
12. Malignancies in bullous pemphigoid: A controversial association.
Balestri R; Magnano M; La Placa M; Patrizi A; Angileri L; Tengattini V; Bardazzi F
J Dermatol; 2016 Feb; 43(2):125-33. PubMed ID: 26435381
[TBL] [Abstract][Full Text] [Related]
13. Bullous pemphigoid and diabetes mellitus: a systematic review and meta-analysis.
Jiirasutat N; Pongchareon P; Weschawalit S
Int J Dermatol; 2024 May; 63(5):572-579. PubMed ID: 38217028
[TBL] [Abstract][Full Text] [Related]
14. Relationship between bullous pemphigoid and malignancy: A Mendelian randomization study.
He MJ; Wang YJ; Ran DL; Fu DS; He Q; Zhang HY; Mao Y; Zhao PY; Yu JB; Zhang JA
J Dermatol; 2024 Mar; 51(3):403-408. PubMed ID: 38212903
[TBL] [Abstract][Full Text] [Related]
15. A population-based study of the association between bullous pemphigoid and neurologic disorders.
Brick KE; Weaver CH; Savica R; Lohse CM; Pittelkow MR; Boeve BF; Gibson LE; Camilleri MJ; Wieland CN
J Am Acad Dermatol; 2014 Dec; 71(6):1191-7. PubMed ID: 25174542
[TBL] [Abstract][Full Text] [Related]
16. Risk of solid malignancies in bullous pemphigoid: A large-scale population-based cohort study.
Kridin K; Hammers CM; Ludwig RJ; Cohen AD
J Dermatol; 2021 Mar; 48(3):317-323. PubMed ID: 33368562
[TBL] [Abstract][Full Text] [Related]
17. Solid and hematological malignancies in patients with bullous pemphigoid: A national cohort study.
Varpuluoma O; Jokelainen J; Huilaja L; Tasanen K
J Am Acad Dermatol; 2024 Feb; 90(2):399-401. PubMed ID: 37804935
[No Abstract] [Full Text] [Related]
18. Mortality in bullous pemphigoid: A systematic review and meta-analysis of standardized mortality ratios.
Kridin K; Schwartz N; Cohen AD; Zelber-Sagi S
J Dermatol; 2018 Sep; 45(9):1094-1100. PubMed ID: 29905389
[TBL] [Abstract][Full Text] [Related]
19. Association of bullous pemphigoid and comorbid health conditions: a case-control study.
Lee S; Rastogi S; Hsu DY; Nardone B; Silverberg JI
Arch Dermatol Res; 2021 Jul; 313(5):327-332. PubMed ID: 32647978
[TBL] [Abstract][Full Text] [Related]
20. Increased Risk of Squamous Cell Carcinoma of the Skin and Lymphoma Among 5,739 Patients with Bullous Pemphigoid: A Swedish Nationwide Cohort Study.
Albadri Z; Thorslund K; Häbel H; Seifert O; Grönhagen C
Acta Derm Venereol; 2020 Oct; 100(17):adv00289. PubMed ID: 32852559
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
